Here's how much Kindred execs made from sale to Humana-led consortium

The closing of the $4.1 billion acquisition of Kindred Healthcare Inc. means that shareholders now can redeem their stake in the company for cash. Kindred and its acquirers — Louisville-based Humana Inc. (NYSE: HUM) and private-equity firms San Francisco-based TPG Capital and New York City-based Welsh, Carson, Anderson& Stowe — closed on the deal Monday. The acquisition was announced in December 2017 and called for the companies to pay $9 a share, or $822 million, for Kindred's stock and…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news